The G Allele of the rs12050217 Polymorphism in the BDKRB1 Gene Is Associated with Protection for Diabetic Retinopathy

References

• Lee R, Wong TY, Sabanayagam C. Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss. Eye Vis (Lond). 2015;2:17. doi:10.1186/s40662-015-0026-2.
   PubMedGoogle Scholar
• Yau JW, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T, Chen SJ, Dekker JM, Fletcher A, Grauslund J, et al. Meta-analysis for eye disease study G. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012;35:556–64. doi:10.2337/dc11-1909.
   PubMed Web of Science ®Google Scholar
• Antonetti DA, Klein R, Gardner TW. Diabetic retinopathy. N Engl J Med. 2012;366:1227–39. doi:10.1056/NEJMra1005073.
   PubMed Web of Science ®Google Scholar
• Lutty GA, Cao J, McLeod DS. Relationship of polymorphonuclear leukocytes to capillary dropout in the human diabetic choroid. Am J Pathol. 1997;151:707–14.
   PubMed Web of Science ®Google Scholar
• Noda K, Nakao S, Ishida S, Ishibashi T. Leukocyte adhesion molecules in diabetic retinopathy. J Ophthalmol. 2012;2012:279037. doi:10.1155/2012/279037.
   PubMed Web of Science ®Google Scholar
• Gardner TW, Antonetti DA, Barber AJ, LaNoue KF, Levison SW. Diabetic retinopathy: more than meets the eye. Surv Ophthalmol. 2002;47:S253–262.
   PubMed Web of Science ®Google Scholar
• Eshaq RS, Aldalati AMZ, Alexander JS, Harris NR. Diabetic retinopathy: breaking the barrier. Pathophysiology. 2017. doi:10.1016/j.pathophys.2017.07.001.
   PubMedGoogle Scholar
• Warpeha KM, Chakravarthy U. Molecular genetics of microvascular disease in diabetic retinopathy. Eye (Lond). 2003;17:305–11. doi:10.1038/sj.eye.6700348.
   PubMed Web of Science ®Google Scholar
• Brondani LA, de Souza BM, Duarte GC, Kliemann LM, Esteves JF, Marcon AS, Gross JL, Canani LH, Crispim D. The ucp1-3826a/g polymorphism is associated with diabetic retinopathy and increased ucp1 and mnsod2 gene expression in human retina. Invest Ophthalmol Vis Sci. 2012;53:7449–57. doi:10.1167/iovs.12-10660.
   PubMed Web of Science ®Google Scholar
• Abhary S, Hewitt AW, Burdon KP, Craig JE. A systematic meta-analysis of genetic association studies for diabetic retinopathy. Diabetes. 2009;58:2137–47. doi:10.2337/db09-0059.
   PubMed Web of Science ®Google Scholar
• Cho H, Sobrin L. Genetics of diabetic retinopathy. Curr Diab Rep. 2014;14:515. doi:10.1007/s11892-014-0475-3.
   PubMed Web of Science ®Google Scholar
• Liu J, Feener EP. Plasma kallikrein-kinin system and diabetic retinopathy. Biol Chem. 2013;394:319–28. doi:10.1515/hsz-2012-0316.
   PubMed Web of Science ®Google Scholar
• Calixto JB, Cabrini DA, Ferreira J, Campos MM. Inflammatory pain: kinins and antagonists. Curr Opin Anaesthesiol. 2001;14:519–26.
   PubMedGoogle Scholar
• Campos MM, Cabrini DA, Cardozo AH, Rae GA, Toro JH, Calixto JB. Changes in paw oedema triggered via bradykinin b(1) and b(2) receptors in streptozotocin-diabetic rats. Eur J Pharmacol. 2001;416:169–77.
   PubMed Web of Science ®Google Scholar
• Mesquita TRR, Campos-Mota GP, Lemos VS, Cruz JS, de Jesus ICG, Camargo EA, Pesquero JL, Pesquero JB, Capettini L, Lauton-Santos S. Vascular kinin b1 and b2 receptors determine endothelial dysfunction through neuronal nitric oxide synthase. Front Physiol. 2017;8:228. doi:10.3389/fphys.2017.00228.
   PubMed Web of Science ®Google Scholar
• Ma JX, Song Q, Hatcher HC, Crouch RK, Chao L, Chao J. Expression and cellular localization of the kallikrein-kinin system in human ocular tissues. Exp Eye Res. 1996;63:19–26. doi:10.1006/exer.1996.0087.
   PubMed Web of Science ®Google Scholar
• Abdouh M, Khanjari A, Abdelazziz N, Ongali B, Couture R, Hassessian HM. Early upregulation of kinin b1 receptors in retinal microvessels of the streptozotocin-diabetic rat. Br J Pharmacol. 2003;140:33–40. doi:10.1038/sj.bjp.0705210.
   PubMed Web of Science ®Google Scholar
• Pouliot M, Talbot S, Senecal J, Dotigny F, Vaucher E, Couture R. Ocular application of the kinin b1 receptor antagonist lf22-0542 inhibits retinal inflammation and oxidative stress in streptozotocin-diabetic rats. PLoS One. 2012;7:e33864. doi:10.1371/journal.pone.0033864.
   PubMed Web of Science ®Google Scholar
• Abdouh M, Talbot S, Couture R, Hassessian HM. Retinal plasma extravasation in streptozotocin-diabetic rats mediated by kinin b(1) and b(2) receptors. Br J Pharmacol. 2008;154:136–43. doi:10.1038/bjp.2008.48.
   PubMed Web of Science ®Google Scholar
• Lawson SR, Gabra BH, Nantel F, Battistini B, Sirois P. Effects of a selective bradykinin b1 receptor antagonist on increased plasma extravasation in streptozotocin-induced diabetic rats: distinct vasculopathic profile of major key organs. Eur J Pharmacol. 2005;514:69–78. doi:10.1016/j.ejphar.2005.03.023.
   PubMed Web of Science ®Google Scholar
• Catanzaro O, Labal E, Andornino A, Capponi JA, Di Martino I, Sirois P. Blockade of early and late retinal biochemical alterations associated with diabetes development by the selective bradykinin b1 receptor antagonist r-954. Peptides. 2012;34:349–52. doi:10.1016/j.peptides.2012.02.008.
   PubMed Web of Science ®Google Scholar
• Pruneau D, Belichard P, Sahel JA, Combal JP. Targeting the kallikrein-kinin system as a new therapeutic approach to diabetic retinopathy. Curr Opin Investig Drugs. 2010;11:507–14.
   PubMed Web of Science ®Google Scholar
• von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, Initiative S. The strengthening the reporting of observational studies in epidemiology (strobe) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61:344–49. doi:10.1016/j.jclinepi.2007.11.008.
   PubMed Web of Science ®Google Scholar
• Little J, Higgins JP, Ioannidis JP, Moher D, Gagnon F, von Elm E, Khoury MJ, Cohen B, Davey-Smith G, Grimshaw J, et al. Strengthening the reporting of genetic association studies (strega): an extension of the strobe statement. Hum Genet. 2009;125:131–51. doi:10.1007/s00439-008-0592-7.
   PubMed Web of Science ®Google Scholar
• Brondani LA, Duarte GC, Canani LH, Crispim D. The presence of at least three alleles of the adrb3 trp64arg (c/t) and ucp1-3826a/g polymorphisms is associated with protection to overweight/obesity and with higher high-density lipoprotein cholesterol levels in Caucasian-Brazilian patients with type 2 diabetes. Metab Syndr Relat Disord. 2014;12:16–24. doi:10.1089/met.2013.0077.
   PubMed Web of Science ®Google Scholar
• American Diabetes A. 2. Classification and diagnosis of diabetes. Diabetes Care. 2017;40:S11–S24. doi:10.2337/dc17-S005.
   PubMedGoogle Scholar
• Wilkinson CP, Ferris FL 3rd, Klein RE, Lee PP, Agardh CD, Davis M, Dills D, Kampik A, Pararajasegaram R, Verdaguer JT. Global Diabetic Retinopathy Project G. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology. 2003;110:1677–82. doi:10.1016/S0161-6420(03)00475-5.
   PubMed Web of Science ®Google Scholar
• Boelter MC, Gross JL, Canani LH, Costa LA, Lisboa HR, Tres GS, Lavinsky J, Azevedo MJ. Proliferative diabetic retinopathy is associated with microalbuminuria in patients with type 2 diabetes. Braz J Med Biol Res. 2006;39:1033–39.
   PubMed Web of Science ®Google Scholar
• Incerti J, Zelmanovitz T, Camargo JL, Gross JL, de Azevedo MJ. Evaluation of tests for microalbuminuria screening in patients with diabetes. Nephrol Dial Transplant. 2005;20:2402–07. doi:10.1093/ndt/gfi074.
   PubMed Web of Science ®Google Scholar
• Zelmanovitz T, Gross JL, Oliveira JR, Paggi A, Tatsch M, Azevedo MJ. The receiver operating characteristics curve in the evaluation of a random urine specimen as a screening test for diabetic nephropathy. Diabetes Care. 1997;20:516–19.
   PubMed Web of Science ®Google Scholar
• Wu H, Roks AJ, Leijten FP, Garrelds IM, Musterd-Bhaggoe UM, van Den Bogaerdt AJ, de Maat MP, Simoons ML, Danser AH, Oeseburg H. Genetic variation and gender determine bradykinin type 1 receptor responses in human tissue: implications for the ACE-inhibitor-induced effects in patients with coronary artery disease. Clin Sci (Lond). 2014;126:441–49. doi:10.1042/CS20130204.
   PubMed Web of Science ®Google Scholar
• Kwak SH, Park KS. Genetic studies on diabetic microvascular complications: focusing on genome-wide association studies. Endocrinol Metab (Seoul). 2015;30:147–58. doi:10.3803/EnM.2015.30.2.147.
   PubMedGoogle Scholar
• Arar NH, Freedman BI, Adler SG, Iyengar SK, Chew EY, Davis MD, Satko SG, Bowden DW, Duggirala R, Elston RC, et al. Heritability of the severity of diabetic retinopathy: the find-eye study. Invest Ophthalmol Vis Sci. 2008;49:3839–45. doi:10.1167/iovs.07-1633.
   PubMed Web of Science ®Google Scholar
• Hietala K, Forsblom C, Summanen P, Groop PH, FinnDiane Study G. Heritability of proliferative diabetic retinopathy. Diabetes. 2008;57:2176–80. doi:10.2337/db07-1495.
   PubMed Web of Science ®Google Scholar
• Ahlqvist E, van Zuydam NR, Groop LC, McCarthy MI. The genetics of diabetic complications. Nat Rev Nephrol. 2015;11:277–87. doi:10.1038/nrneph.2015.37.
   PubMed Web of Science ®Google Scholar
• Yang X, Polgar P. Genomic structure of the human bradykinin b1 receptor gene and preliminary characterization of its regulatory regions. Biochem Biophys Res Commun. 1996;222:718–25. doi:10.1006/bbrc.1996.0810.
   PubMed Web of Science ®Google Scholar
• Johnson AD, Handsaker RE, Pulit SL, Nizzari MM, O‘Donnell CJ, de Bakker PI. Snap: A web-based tool for identification and annotation of proxy SNPs using hapmap. Bioinformatics. 2008;24:2938–39. doi:10.1093/bioinformatics/btn564.
   PubMed Web of Science ®Google Scholar
• Naslavsky MS, Yamamoto GL, de Almeida TF, Ezquina SAM, Sunaga DY, Pho N, Bozoklian D, Sandberg TOM, Brito LA, Lazar M, et al. Exomic variants of an elderly cohort of Brazilians in the ABraOM database. Hum Mutat. 2017;38:751–63. doi:10.1002/humu.23220.
   PubMed Web of Science ®Google Scholar
• Austinat M, Braeuninger S, Pesquero JB, Brede M, Bader M, Stoll G, Renne T, Kleinschnitz C. Blockade of bradykinin receptor b1 but not bradykinin receptor b2 provides protection from cerebral infarction and brain edema. Stroke. 2009;40:285–93. doi:10.1161/STROKEAHA.108.526673.
   PubMed Web of Science ®Google Scholar
• Murakami T. Kallikrein-kinin system: an emerging competitor or collaborator for VEGF in diabetic macular edema? Diabetes. 2015;64:3350–52. doi:10.2337/db15-0746.
   PubMed Web of Science ®Google Scholar
• Mejia AJ, Matus CE, Pavicic F, Concha M, Ehrenfeld P, Figueroa CD. Intracellular signaling pathways involved in the release of IL-4 and VEGF from human keratinocytes by activation of kinin b1 receptor: functional relevance to angiogenesis. Arch Dermatol Res. 2015;307:803–17. doi:10.1007/s00403-015-1595-6.
   PubMed Web of Science ®Google Scholar
• Duchene J, Lecomte F, Ahmed S, Cayla C, Pesquero J, Bader M, Perretti M, Ahluwalia A. A novel inflammatory pathway involved in leukocyte recruitment: role for the kinin b1 receptor and the chemokine cxcl5. J Immunol. 2007;179:4849–56.
   PubMed Web of Science ®Google Scholar
• Pesquero JB, Araujo RC, Heppenstall PA, Stucky CL, Silva JA Jr., Walther T, Oliveira SM, Pesquero JL, Paiva AC, Calixto JB, et al. Hypoalgesia and altered inflammatory responses in mice lacking kinin b1 receptors. Proc Natl Acad Sci U S A. 2000;97:8140–45. doi:10.1073/pnas.120035997.
   PubMed Web of Science ®Google Scholar
• Joussen AM, Poulaki V, Mitsiades N, Cai WY, Suzuma I, Pak J, Ju ST, Rook SL, Esser P, Mitsiades CS, et al. Suppression of fas-fasl-induced endothelial cell apoptosis prevents diabetic blood-retinal barrier breakdown in a model of streptozotocin-induced diabetes. FASEB J. 2003;17:76–78. doi:10.1096/fj.02-0157fje.
   PubMed Web of Science ®Google Scholar
• Miyamoto K, Khosrof S, Bursell SE, Rohan R, Murata T, Clermont AC, Aiello LP, Ogura Y, Adamis AP. Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition. Proc Natl Acad Sci U S A. 1999;96:10836–41.
   PubMed Web of Science ®Google Scholar
• Tang S, Le-Ruppert KC. Activated T lymphocytes in epiretinal membranes from eyes of patients with proliferative diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol. 1995;233:21–25.
   PubMed Web of Science ®Google Scholar
• Kase S, Saito W, Ohno S, Ishida S. Proliferative diabetic retinopathy with lymphocyte-rich epiretinal membrane associated with poor visual prognosis. Invest Ophthalmol Vis Sci. 2009;50:5909–12. doi:10.1167/iovs.09-3767.
   PubMed Web of Science ®Google Scholar
• Figueroa CD, Matus CE, Pavicic F, Sarmiento J, Hidalgo MA, Burgos RA, Gonzalez CB, Bhoola KD, Ehrenfeld P. Kinin b1 receptor regulates interactions between neutrophils and endothelial cells by modulating the levels of mac-1, lfa-1 and intercellular adhesion molecule-1. Innate Immun. 2015;21:289–304. doi:10.1177/1753425914529169.
   PubMed Web of Science ®Google Scholar
• Toda N, Nakanishi-Toda M. Nitric oxide: ocular blood flow, glaucoma, and diabetic retinopathy. Prog Retin Eye Res. 2007;26:205–38. doi:10.1016/j.preteyeres.2007.01.004.
   PubMed Web of Science ®Google Scholar
• Leeb-Lundberg LM, Marceau F, Muller-Esterl W, Pettibone DJ, Zuraw BL. International union of pharmacology. Xlv. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences. Pharmacol Rev. 2005;57:27–77. doi:10.1124/pr.57.1.2.
   PubMed Web of Science ®Google Scholar
• Pesquero JB, Bader M. Genetically altered animal models in the kallikrein-kinin system. Biol Chem. 2006;387:119–26. doi:10.1515/BC.2006.017.
   PubMed Web of Science ®Google Scholar
• Busse R, Fleming I. Molecular responses of endothelial tissue to kinins. Diabetes. 1996;45:S8–13.
   PubMed Web of Science ®Google Scholar
• Kuhr F, Lowry J, Zhang Y, Brovkovych V, Skidgel RA. Differential regulation of inducible and endothelial nitric oxide synthase by kinin b1 and b2 receptors. Neuropeptides. 2010;44:145–54. doi:10.1016/j.npep.2009.12.004.
   PubMed Web of Science ®Google Scholar
• Brovkovych V, Zhang Y, Brovkovych S, Minshall RD, Skidgel RA. A novel pathway for receptor-mediated post-translational activation of inducible nitric oxide synthase. J Cell Mol Med. 2011;15:258–69. doi:10.1111/j.1582-4934.2009.00992.x.
   PubMed Web of Science ®Google Scholar
• Cicik E, Tekin H, Akar S, Ekmekci OB, Donma O, Koldas L, Ozkan S. Interleukin-8, nitric oxide and glutathione status in proliferative vitreoretinopathy and proliferative diabetic retinopathy. Ophthalmic Res. 2003;35:251–55. doi:10.1159/000072145.
   PubMed Web of Science ®Google Scholar